Thymosin Alpha-1 (10mg)

Thymosin Alpha-1 (10mg) protocols focus on this synthetic peptide derived from thymosin fraction 5, studied for its immune-modulating properties. It is researched for its potential role in supporting immune system balance, enhancing T-cell function, and promoting resilience against immune stress. This guide outlines a subcutaneous administration approach optimized for the 10 mg vial format.

  • Reconstitute: Add 2.0 mL bacteriostatic water → 5 mg/mL concentration
  • Typical dosing range: 0.5–2 mg per dose (subcutaneous)
  • Easy measuring: At 5 mg/mL, 1 unit = 0.01 mL = 50 mcg (0.05 mg) on a U-100 insulin syringe
  • Storage: Lyophilized: store at −20 °C; after reconstitution, refrigerate at 2–8 °C and use within 2–4 weeks

Concise summary of the subcutaneous regimen.

  • Goal: Support immune regulation and T-cell activity
  • Schedule: 2–5 injections per week or daily during immune support cycles
  • Dose Range: 0.5–2 mg per administration

Suggested approach for the 10 mg vial format.

  • Start: 0.5 mg 2–3 times per week to assess tolerance
  • Target: 1–2 mg per dose, 2–5 times weekly or short daily cycles
  • Frequency: Intermittent or daily, depending on protocol purpose
  • Vial Duration: One 10 mg vial lasts approximately 5–20 doses depending on use
  • Timing: Flexible; often administered consistently at the same time of day

Thymosin Alpha-1 (Tα1) is a synthetic version of a naturally occurring thymic peptide involved in immune system regulation. It primarily acts by enhancing T-cell maturation and differentiation, improving the body’s adaptive immune response.

It has been studied for its ability to modulate cytokine production, balance immune activation, and support antiviral and antimicrobial defense mechanisms. Thymosin Alpha-1 does not overstimulate the immune system but instead helps restore immune balance, particularly in states of immune dysfunction or stress. Its immunomodulatory properties have been explored in viral infections, chronic illness, and immunocompromised conditions.

Observations based on clinical research and immune studies.

Potential Benefits:

  • May support immune system regulation and balance
  • May enhance T-cell function and immune responsiveness
  • May support recovery during illness or immune stress
  • May improve overall immune resilience

Possible Side Effects:

  • Mild injection-site irritation
  • Occasional fatigue or flu-like sensations
  • Rare headache or temporary discomfort
  • Generally well tolerated in clinical studies; long-term unsupervised use not fully established